Full Name
Jim Poole
Speaker Bio
Jim Poole is a seasoned healthcare and technology executive with more than three decades of experience building and leading organizations at the intersection of science, innovation, and human performance. As CEO of NuCalm, he is the visionary who oversees the strategic direction of the world’s only patented neuroscience technology clinically proven to lower stress, balance the nervous system, improve sleep quality, and enhance performance—safely, naturally, and without drugs.
Since 2009, Poole has guided NuCalm’s evolution into a global leader in applied neuroscience. Backed by 36 years of neuroscience research, $52 million in development, and two patents, NuCalm has been used during 2.7 million medical procedures and adopted by the U.S. military, professional athletes, physicians, pilots, and more. Under his leadership, the company continues to expand its mission of helping people regain control of their health, energy, and peace of mind.
Giving back is part of NuCalm’s DNA. They donate products and services through various humanitarian and charitable organizations, including Mission 22, a non-profit organization that provides treatment programs for Post-Traumatic Stress, and suicide awareness and prevention. They also support cancer patients at the Comprehensive Cancer Wellness Program, first responders, people battling trauma and addiction, and people battling Multiple Sclerosis. As part of NuCalm’s mission to be an agent of change, Poole traveled to Kenya to inspire students through business and personal development, as well as donating funds to universities. NuCalm has also provided aid during the California Wildfires, the Russian War with Ukraine and the Kerrville, Texas flood. The company does the right thing when no one is looking and serves people with the biggest need, but often the quietest voice.
Prior to NuCalm, Poole founded Focused Evolution, a global strategy consulting firm advising private equity and venture capital clients on growth strategies, mergers and acquisitions, and market expansion. He led the largest private equity acquisition in the history of the dental industry for Credit Suisse DLJ Merchant Banking Partners, driving operational excellence and value creation at scale. His career spans healthcare, biotechnology, finance, and information technology—experience that informs his ability to navigate complexity, align science with purpose, and deliver innovation with integrity.
A recognized thought leader in neuropsychobiology, stress physiology, sleep science, and human recovery, Poole has lectured internationally at distinguished institutions and forums, including the Royal College of Physicians in London, the World Congress for Brain Mapping and Therapeutics, Parliament, the Pentagon, Quantico, the NFL Combine, and the Consumer Electronics Show. NuCalm’s work has been featured in The Wall Street Journal, Forbes, The New York Times, NASDAQ, MSNBC, CBS, Access Hollywood, and the TODAY Show.
Poole is the recipient of the President’s Lifetime Achievement Award for servant leadership and contributions to humankind. He believes deeply that science should serve humanity and that true innovation empowers people to live calmer, clearer, and more connected lives. His life’s work is dedicated to advancing neuroscience solutions that make resilience, recovery, and well-being accessible to all.
Since 2009, Poole has guided NuCalm’s evolution into a global leader in applied neuroscience. Backed by 36 years of neuroscience research, $52 million in development, and two patents, NuCalm has been used during 2.7 million medical procedures and adopted by the U.S. military, professional athletes, physicians, pilots, and more. Under his leadership, the company continues to expand its mission of helping people regain control of their health, energy, and peace of mind.
Giving back is part of NuCalm’s DNA. They donate products and services through various humanitarian and charitable organizations, including Mission 22, a non-profit organization that provides treatment programs for Post-Traumatic Stress, and suicide awareness and prevention. They also support cancer patients at the Comprehensive Cancer Wellness Program, first responders, people battling trauma and addiction, and people battling Multiple Sclerosis. As part of NuCalm’s mission to be an agent of change, Poole traveled to Kenya to inspire students through business and personal development, as well as donating funds to universities. NuCalm has also provided aid during the California Wildfires, the Russian War with Ukraine and the Kerrville, Texas flood. The company does the right thing when no one is looking and serves people with the biggest need, but often the quietest voice.
Prior to NuCalm, Poole founded Focused Evolution, a global strategy consulting firm advising private equity and venture capital clients on growth strategies, mergers and acquisitions, and market expansion. He led the largest private equity acquisition in the history of the dental industry for Credit Suisse DLJ Merchant Banking Partners, driving operational excellence and value creation at scale. His career spans healthcare, biotechnology, finance, and information technology—experience that informs his ability to navigate complexity, align science with purpose, and deliver innovation with integrity.
A recognized thought leader in neuropsychobiology, stress physiology, sleep science, and human recovery, Poole has lectured internationally at distinguished institutions and forums, including the Royal College of Physicians in London, the World Congress for Brain Mapping and Therapeutics, Parliament, the Pentagon, Quantico, the NFL Combine, and the Consumer Electronics Show. NuCalm’s work has been featured in The Wall Street Journal, Forbes, The New York Times, NASDAQ, MSNBC, CBS, Access Hollywood, and the TODAY Show.
Poole is the recipient of the President’s Lifetime Achievement Award for servant leadership and contributions to humankind. He believes deeply that science should serve humanity and that true innovation empowers people to live calmer, clearer, and more connected lives. His life’s work is dedicated to advancing neuroscience solutions that make resilience, recovery, and well-being accessible to all.
Speaking At
